DONGSUNG CHEMICAL Toekomstige groei

Future criteriumcontroles 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for DONGSUNG CHEMICAL.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

Chemicals winstgroei	67.8%
Inkomstengroei	n/a
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	None
Laatst bijgewerkt	n/a

Recente toekomstige groei-updates

Geen updates

Recent updates

What Type Of Shareholders Make Up Dongsung Corporation's (KRX:102260) Share Registry?

Feb 18

What Type Of Returns Would Dongsung's(KRX:102260) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

Jan 31

Our Take On The Returns On Capital At Dongsung (KRX:102260)

Jan 13

Just Three Days Till Dongsung Corporation (KRX:102260) Will Be Trading Ex-Dividend

Dec 24

Would Dongsung Corporation (KRX:102260) Be Valuable To Income Investors?

Dec 14

Should You Use Dongsung's (KRX:102260) Statutory Earnings To Analyse It?

Nov 26

In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat DONGSUNG CHEMICAL onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.

Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.

Winst- en omzetgroeiprognoses

KOSE:A102260 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (KRW Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
6/30/2024	1,116,478	29,957	58,303	146,679	N/A
3/31/2024	1,124,566	35,015	110,159	187,403	N/A
12/31/2023	1,117,999	33,454	81,530	134,210	N/A
9/30/2023	1,070,417	41,819	112,101	155,034	N/A
6/30/2023	1,073,597	35,074	39,467	81,783	N/A
3/31/2023	1,109,790	41,263	-8,627	26,435	N/A
12/31/2022	1,140,124	35,041	18,632	53,187	N/A
9/30/2022	1,104,602	23,332	-44,619	-20,284	N/A
6/30/2022	1,037,659	20,624	-47,726	-28,498	N/A
3/31/2022	957,254	13,349	-46,280	-26,581	N/A
12/31/2021	925,979	16,961	-35,114	-16,320	N/A
9/30/2021	873,561	11,250	11,164	31,791	N/A
6/30/2021	885,193	11,593	55,644	73,959	N/A
3/31/2021	879,469	12,496	91,628	107,872	N/A
12/31/2020	864,010	13,689	103,541	122,765	N/A
9/30/2020	884,567	11,404	92,916	107,085	N/A
6/30/2020	880,578	9,730	74,475	93,855	N/A
3/31/2020	877,056	7,673	33,948	59,747	N/A
12/31/2019	849,786	5,635	22,824	45,562	N/A
9/30/2019	837,742	1,596	22,644	48,773	N/A
6/30/2019	831,002	-3,418	9,268	33,206	N/A
3/31/2019	818,057	-6,049	8,842	26,933	N/A
12/31/2018	813,073	-3,219	29,354	47,656	N/A
9/30/2018	792,837	1,523	13,087	42,667	N/A
6/30/2018	788,921	9,569	35,831	70,703	N/A
3/31/2018	806,266	9,201	N/A	74,182	N/A
12/31/2017	827,336	9,813	N/A	47,209	N/A
9/30/2017	850,580	20,190	N/A	32,380	N/A
6/30/2017	839,401	22,089	N/A	15,334	N/A
3/31/2017	841,381	32,253	N/A	28,621	N/A
12/31/2016	852,913	37,469	N/A	78,305	N/A
9/30/2016	853,514	30,534	N/A	74,164	N/A
6/30/2016	890,103	30,945	N/A	67,409	N/A
3/31/2016	901,650	25,859	N/A	89,315	N/A
12/31/2015	871,225	20,288	N/A	49,658	N/A
9/30/2015	920,032	16,559	N/A	72,147	N/A
6/30/2015	898,011	11,686	N/A	66,378	N/A
3/31/2015	887,272	9,572	N/A	53,378	N/A
12/31/2014	905,441	7,282	N/A	62,340	N/A
9/30/2014	848,663	13,280	N/A	64,416	N/A
6/30/2014	860,799	8,321	N/A	60,524	N/A
3/31/2014	848,759	1,719	N/A	60,394	N/A
12/31/2013	823,410	599	N/A	61,456	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Insufficient data to determine if A102260's forecast earnings growth is above the savings rate (2.6%).

Winst versus markt: Insufficient data to determine if A102260's earnings are forecast to grow faster than the KR market

Hoge groeiwinsten: Insufficient data to determine if A102260's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: Insufficient data to determine if A102260's revenue is forecast to grow faster than the KR market.

Hoge groei-inkomsten: Insufficient data to determine if A102260's revenue is forecast to grow faster than 20% per year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Insufficient data to determine if A102260's Return on Equity is forecast to be high in 3 years time

DONGSUNG CHEMICAL Toekomstige groei

Future criteriumcontroles 0/6

Belangrijke informatie

Recente toekomstige groei-updates

Recent updates

Some May Be Optimistic About DONGSUNG CHEMICAL's (KRX:102260) Earnings

SK Chemicals, Dongsung Chemical, and Black Yak Collaborate on Commercializing Sustainable Footwear

SG Private Equity Co., Ltd. completed the acquisition of Dongsung TCS Co., Ltd. from Dongsung Chemical Co., Ltd. (KOSE:A102260).

Does DONGSUNG CHEMICAL (KRX:102260) Have A Healthy Balance Sheet?

SG Private Equity Co., Ltd. agreed to acquire Dongsung TCS Co., Ltd. from Dongsung Chemical Co., Ltd. (KOSE:A102260) for KRW 31.6 billion

SG Private Equity Co., Ltd. agreed to acquire Dongsung TCS Co., Ltd. from Dongsung Chemical Co., Ltd. (KOSE:A102260) for KRW 31.6 billion

Upcoming dividend of ₩200 per share at 4.3% yield

Investor sentiment improves as stock rises 25%

Full year 2022 earnings released: EPS: ₩714 (vs ₩351 in FY 2021)

Upcoming dividend of ₩200 per share

Less than half of directors are independent

Dongsung Chemical Co., Ltd. (KOSE:A102260) announces an Equity Buyback for KRW 2,000 million worth of its shares.

Less than half of directors are independent

Upcoming dividend of ₩250 per share

Should You Buy Dongsung Corporation (KRX:102260) For Its 3.6% Dividend?

Full year 2020 earnings released: EPS ₩152 (vs ₩128 in FY 2019)

Dongsung (KRX:102260) Seems To Use Debt Quite Sensibly

Dongsung Corporation, Annual General Meeting, Mar 24, 2021